Clinical Trial Update: The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating melatonin for gastroesophageal reflux disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Mansoura University | Conditions: Gastroesophageal Reflux Disease | Phase 3 | Status: WITHDRAWN